Report Detail

Other Global Antihormonal Cancer Therapies Market Size, Status and Forecast 2019-2025

  • RnM3820389
  • |
  • 08 November, 2019
  • |
  • Global
  • |
  • 95 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Radiations
      • 1.4.3 Drugs
      • 1.4.4 Surgeries
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Antihormonal Cancer Therapies Market Share by Application (2019-2025)
      • 1.5.2 Breast Cancer
      • 1.5.3 Prostate Cancer
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Antihormonal Cancer Therapies Market Size
    • 2.2 Antihormonal Cancer Therapies Growth Trends by Regions
      • 2.2.1 Antihormonal Cancer Therapies Market Size by Regions (2019-2025)
      • 2.2.2 Antihormonal Cancer Therapies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Antihormonal Cancer Therapies Market Size by by Players
      • 3.1.1 Global Antihormonal Cancer Therapies Revenue by by Players (2014-2019)
      • 3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antihormonal Cancer Therapies Key Players Head office and Area Served
    • 3.3 Key Players Antihormonal Cancer Therapies Product/Solution/Service
    • 3.4 Date of Enter into Antihormonal Cancer Therapies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Antihormonal Cancer Therapies Market Size by Type (2014-2019)
    • 4.2 Global Antihormonal Cancer Therapies Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Antihormonal Cancer Therapies Market Size (2014-2019)
    • 5.2 Antihormonal Cancer Therapies Key Players in North America
    • 5.3 North America Antihormonal Cancer Therapies Market Size by Type
    • 5.4 North America Antihormonal Cancer Therapies Market Size by Application

    6 Europe

    • 6.1 Europe Antihormonal Cancer Therapies Market Size (2014-2019)
    • 6.2 Antihormonal Cancer Therapies Key Players in Europe
    • 6.3 Europe Antihormonal Cancer Therapies Market Size by Type
    • 6.4 Europe Antihormonal Cancer Therapies Market Size by Application

    7 China

    • 7.1 China Antihormonal Cancer Therapies Market Size (2014-2019)
    • 7.2 Antihormonal Cancer Therapies Key Players in China
    • 7.3 China Antihormonal Cancer Therapies Market Size by Type
    • 7.4 China Antihormonal Cancer Therapies Market Size by Application

    8 Japan

    • 8.1 Japan Antihormonal Cancer Therapies Market Size (2014-2019)
    • 8.2 Antihormonal Cancer Therapies Key Players in Japan
    • 8.3 Japan Antihormonal Cancer Therapies Market Size by Type
    • 8.4 Japan Antihormonal Cancer Therapies Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Antihormonal Cancer Therapies Market Size (2014-2019)
    • 9.2 Antihormonal Cancer Therapies Key Players in Southeast Asia
    • 9.3 Southeast Asia Antihormonal Cancer Therapies Market Size by Type
    • 9.4 Southeast Asia Antihormonal Cancer Therapies Market Size by Application

    10 India

    • 10.1 India Antihormonal Cancer Therapies Market Size (2014-2019)
    • 10.2 Antihormonal Cancer Therapies Key Players in India
    • 10.3 India Antihormonal Cancer Therapies Market Size by Type
    • 10.4 India Antihormonal Cancer Therapies Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Antihormonal Cancer Therapies Market Size (2014-2019)
    • 11.2 Antihormonal Cancer Therapies Key Players in Central & South America
    • 11.3 Central & South America Antihormonal Cancer Therapies Market Size by Type
    • 11.4 Central & South America Antihormonal Cancer Therapies Market Size by Application

    12 International Players Profiles

    • 12.1 AstraZeneca
      • 12.1.1 AstraZeneca Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Antihormonal Cancer Therapies Introduction
      • 12.1.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2014-2019))
      • 12.1.5 AstraZeneca Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Antihormonal Cancer Therapies Introduction
      • 12.2.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Antihormonal Cancer Therapies Introduction
      • 12.3.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Sanofi
      • 12.4.1 Sanofi Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Antihormonal Cancer Therapies Introduction
      • 12.4.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.4.5 Sanofi Recent Development
    • 12.5 Takeda
      • 12.5.1 Takeda Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Antihormonal Cancer Therapies Introduction
      • 12.5.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.5.5 Takeda Recent Development
    • 12.6 Roche
      • 12.6.1 Roche Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Antihormonal Cancer Therapies Introduction
      • 12.6.4 Roche Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.6.5 Roche Recent Development
    • 12.7 Amgen
      • 12.7.1 Amgen Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Antihormonal Cancer Therapies Introduction
      • 12.7.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.7.5 Amgen Recent Development
    • 12.8 Samyang Biopharmaceuticals
      • 12.8.1 Samyang Biopharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Antihormonal Cancer Therapies Introduction
      • 12.8.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.8.5 Samyang Biopharmaceuticals Recent Development
    • 12.9 Tolmar
      • 12.9.1 Tolmar Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Antihormonal Cancer Therapies Introduction
      • 12.9.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.9.5 Tolmar Recent Development
    • 12.10 Bluebird Bio
      • 12.10.1 Bluebird Bio Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Antihormonal Cancer Therapies Introduction
      • 12.10.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2014-2019)
      • 12.10.5 Bluebird Bio Recent Development
    • 12.11 Bristol-Myers Squibb
    • 12.12 Exelixis
    • 12.13 Guardant Health
    • 12.14 Illumina

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Antihormonal Cancer Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antihormonal Cancer Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AstraZeneca
      Novartis
      Pfizer
      Sanofi
      Takeda
      Roche
      Amgen
      Samyang Biopharmaceuticals
      Tolmar
      Bluebird Bio
      Bristol-Myers Squibb
      Exelixis
      Guardant Health
      Illumina

      Market segment by Type, the product can be split into
      Radiations
      Drugs
      Surgeries
      Others

      Market segment by Application, split into
      Breast Cancer
      Prostate Cancer
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Antihormonal Cancer Therapies status, future forecast, growth opportunity, key market and key players.
      To present the Antihormonal Cancer Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Antihormonal Cancer Therapies are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Antihormonal Cancer Therapies. Industry analysis & Market Report on Antihormonal Cancer Therapies is a syndicated market report, published as Global Antihormonal Cancer Therapies Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Antihormonal Cancer Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,027.15
      4,540.73
      6,054.31
      3,535.89
      5,303.83
      7,071.78
      423,852.00
      635,778.00
      847,704.00
      279,983.73
      419,975.60
      559,967.46
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report